Biomarkers for treatment outcome in newly diagnosed epilepsy
Introduction and aims Epilepsy is a common neurological condition and around 25% of patients are resistant to treatment with currently available drugs (Brodie et al., 2012). Currently there is only a limited ability to predict treatment outcome and no genome based biomarkers for treatment efficacy....
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Liverpool
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.722053 |